Skip to content
2000
Volume 17, Issue 2
  • ISSN: 2589-9775
  • E-ISSN: 2589-9783

Abstract

Background

Pancreatic neoplasm is one of the types of cancer with a high incidence and case-fatality rate.

Objectives

This study was designed to investigate the relationship between statin intake and the risk of pancreatic cancer with a systematic review and meta-analysis approach.

Methods

This study was a systematic review and meta-analysis of studies published before 2023 in Cochrane Library, Web of Science (WOS), PubMed, Google Scholar, ScienceDirect, Scopus, and Embase databases. The statistical analyses were conducted using Stata software, version 15. The significance level for this study was set at 0.05.

Results

This meta-analysis included 32 studies and a total of 5,849,814 participants. The risk ratio (RR) of pancreatic cancer in comparison to the non-statin receiving group in statin users in total was equal to 0.75 (95% CI: 0.66-0.86, -value <0.001), in the cohort studies was obtained to be 0.70 (0.53-0.93), in the randomized clinical trials (RCTs) had a ratio of 0.99 (0.53-1.86), while studies conducted in American countries had a ratio of 0.69 (0.51-0.93), studies in Asian countries had a ratio of 0.73 (0.56-0.97), and studies in European countries had a ratio of 0.88 (0.76-1.02). Furthermore, the study did not detect any signs of publication bias.

Conclusion

The study findings suggest a potential connection between using statins and a lower risk of pancreatic cancer. However, it is important to note that controlled clinical trials did not find a statistically significant association between taking statins and the development of pancreatic cancer. Therefore, it is advisable to exercise caution when interpreting the results of this study.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdrr/10.2174/0125899775281869240311043637
2024-03-20
2025-09-26

  • From This Site

    /content/journals/cdrr/10.2174/0125899775281869240311043637
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SungH. FerlayJ. SiegelR.L. LaversanneM. SoerjomataramI. JemalA. BrayF. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202171320924910.3322/caac.2166033538338
     [Google Scholar]
  2. FerlayJ. ColombetM. SoerjomataramI. ParkinD.M. PiñerosM. ZnaorA. BrayF. Cancer statistics for the year 2020: An overview.Int. J. Cancer2021149477878910.1002/ijc.3358833818764
     [Google Scholar]
  3. DeoS.V.S. SharmaJ. KumarS. GLOBOCAN 2020 report on global cancer burden: Challenges and opportunities for surgical oncologists.Ann. Surg. Oncol.202229116497650010.1245/s10434‑022‑12151‑635838905
     [Google Scholar]
  4. AnsariD. TingstedtB. AnderssonB. HolmquistF. SturessonC. WilliamssonC. SasorA. BorgD. BaudenM. AnderssonR. Pancreatic cancer: Yesterday, today and tomorrow.Future Oncol.201612161929194610.2217/fon‑2016‑001027246628
     [Google Scholar]
  5. BrayF. FerlayJ. SoerjomataramI. SiegelR.L. TorreL.A. JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.201868639442410.3322/caac.2149230207593
     [Google Scholar]
  6. BosettiC. BraviF. TuratiF. EdefontiV. PoleselJ. DecarliA. NegriE. TalaminiR. FranceschiS. La VecchiaC. ZeegersM.P. Nutrient-based dietary patterns and pancreatic cancer risk.Ann. Epidemiol.201323312412810.1016/j.annepidem.2012.12.00523332711
     [Google Scholar]
  7. YehJ.J. LaiJ.N. LinC.L. HsuC.Y. KaoC.H. Time-dependent propensity-matched general population study of the effects of statin use on cancer risk in an interstitial lung disease and pulmonary fibrosis cohort.BMJ Open20211110e04703910.1136/bmjopen‑2020‑04703934635513
     [Google Scholar]
  8. Stolzenberg-SolomonR.Z. PietinenP. TaylorP.R. VirtamoJ. AlbanesD. Prospective study of diet and pancreatic cancer in male smokers.Am. J. Epidemiol.2002155978379210.1093/aje/155.9.78311978580
     [Google Scholar]
  9. VrecerM. TurkS. DrinovecJ. MrharA. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.Int. J. Clin. Pharmacol. Ther.2003411256757710.5414/CPP4156714692706
     [Google Scholar]
  10. LaiS.W. KuoY.H. LiaoK.F. Statins and pancreatic cancer risk.J. Gastroenterol.202055447147210.1007/s00535‑020‑01675‑x32036452
     [Google Scholar]
  11. CarrerA. TrefelyS. ZhaoS. CampbellS.L. NorgardR.J. SchultzK.C. SidoliS. ParrisJ.L.D. AffrontiH.C. SivanandS. EgolfS. SelaY. TrizzinoM. GardiniA. GarciaB.A. SnyderN.W. StangerB.Z. WellenK.E. Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis.Cancer Discov.20199341643510.1158/2159‑8290.CD‑18‑056730626590
     [Google Scholar]
  12. GongJ. SachdevE. RobbinsL.A. LinE. HendifarA.E. MitaM.M. Statins and pancreatic cancer.Oncol. Lett.20171331035104010.3892/ol.2017.557228454210
     [Google Scholar]
  13. WalkerE.J. KoA.H. HollyE.A. BracciP.M. Statin use and risk of pancreatic cancer: Results from a large, clinic-based case-control study.Cancer201512181287129410.1002/cncr.2925625649483
     [Google Scholar]
  14. BangU.C. WatanabeT. BendtsenF. The relationship between the use of statins and mortality, severity, and pancreatic cancer in Danish patients with chronic pancreatitis.Eur. J. Gastroenterol. Hepatol.201830334635110.1097/MEG.000000000000106029309396
     [Google Scholar]
  15. ChoiJ.H. LeeS.H. HuhG. ChunJ.W. YouM.S. PaikW.H. RyuJ.K. KimY.T. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.Cancer Med.20198177419743010.1002/cam4.261731637875
     [Google Scholar]
  16. SaitoK. SatoY. NakataniE. KanedaH. YamamotoS. MiyachiY. ItohH. Statin exposure and pancreatic cancer incidence: A Japanese regional population-based cohort study, the shizuoka study.Cancer Prev. Res.202114986387210.1158/1940‑6207.CAPR‑21‑012334244151
     [Google Scholar]
  17. ArchibugiL. PiciucchiM. StiglianoS. ValenteR. ZerboniG. BaruccaV. MilellaM. MaisonneuveP. Delle FaveG. CapursoG. Exclusive and combined use of statins and aspirin and the risk of pancreatic cancer: A case-control study.Sci. Rep.2017711302410.1038/s41598‑017‑13430‑z29026148
     [Google Scholar]
  18. KhuranaV. ChicoG. JaganmohanS. BarkinJ.S. Statins reduce the risk of pancreatic cancer in humans: Half a million veterans’ case control study.Pancreas200429436810.1097/00006676‑200411000‑00157
     [Google Scholar]
  19. GraafM.R. BeiderbeckA.B. EgbertsA.C.G. RichelD.J. GuchelaarH.J. The risk of cancer in users of statins.J. Clin. Oncol.200422122388239410.1200/JCO.2004.02.02715197200
     [Google Scholar]
  20. KhuranaV. ShethA. CalditoG. BarkinJ.S. Statins reduce the risk of pancreatic cancer in humans: A case-control study of half a million veterans.Pancreas200734226026510.1097/MPA.0b013e318030e96317312467
     [Google Scholar]
  21. ChenM.J. TsanY.T. LiouJ.M. LeeY.C. WuM.S. ChiuH.M. WangH.P. ChenP.C. Statins and the risk of pancreatic cancer in Type 2 diabetic patients: A population‐based cohort study.Int. J. Cancer2016138359460310.1002/ijc.2981326296262
     [Google Scholar]
  22. CooganP.F. RosenbergL. StromB.L. Statin use and the risk of 10 cancers.Epidemiology200718221321910.1097/01.ede.0000254694.03027.a117235211
     [Google Scholar]
  23. KarpI. BehlouliH. LeLorierJ. PiloteL. Statins and cancer risk.Am. J. Med.2008121430230910.1016/j.amjmed.2007.12.01118374689
     [Google Scholar]
  24. HaukkaJ. SankilaR. KlaukkaT. LonnqvistJ. NiskanenL. TanskanenA. WahlbeckK. TiihonenJ. Incidence of cancer and statin usage—Record linkage study.Int. J. Cancer2010126127928410.1002/ijc.2453619739258
     [Google Scholar]
  25. BradleyM.C. HughesC.M. CantwellM.M. MurrayL.J. Statins and pancreatic cancer risk: A nested case–control study.Cancer Causes Control201021122093210010.1007/s10552‑010‑9628‑020697797
     [Google Scholar]
  26. KirkegårdJ. LundJ.L. MortensenF.V. Cronin-FentonD. Statins and pancreatic cancer risk in patients with chronic pancreatitis: A Danish nationwide population-based cohort study.Int. J. Cancer2020146361061610.1002/ijc.3226430861115
     [Google Scholar]
  27. SimonM.S. DesaiP. WallaceR. WuC. HowardB.V. MartinL.W. SchlechtN. LiuS. JayA. LeBlancE.S. RohanT. MansonJ. Prospective analysis of association between statins and pancreatic cancer risk in the Women’s Health Initiative.Cancer Causes Control201627341542310.1007/s10552‑016‑0717‑626857832
     [Google Scholar]
  28. ClearfieldM. DownsJ.R. WeisS. WhitneyE.J. KruyerW. ShapiroD.R. SteinE.A. LangendorferA. BeereP.A. GottoA.M. Air Force/Texas Coronary Atherosclerosis Prevention Study Air force/texas coronary atherosclerosis prevention study (AFCAPS/TexCAPS): Efficacy and tolerability of long-term treatment with lovastatin in women.J. Womens Health Gend. Based Med.2001101097198110.1089/15246090131719354911788107
     [Google Scholar]
  29. ChiuH.F. ChangC.C. HoS.C. WuT.N. YangC.Y. Statin use and the risk of pancreatic cancer: A population-based case-control study.Pancreas201140566967210.1097/MPA.0b013e31821fd5cd21654539
     [Google Scholar]
  30. JacobsE.J. NewtonC.C. ThunM.J. GapsturS.M. Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort.Cancer Res.20117151763177110.1158/0008‑5472.CAN‑10‑295321343395
     [Google Scholar]
  31. CareyF.J. LittleM.W. PughT.F.G. NdokeraR. IngH. ClarkA. DennisonA. MetcalfeM.S. RobinsonR.J. HartA.R. The differential effects of statins on the risk of developing pancreatic cancer: A case-control study in two centres in the United Kingdom.Dig. Dis. Sci.201358113308331210.1007/s10620‑013‑2778‑723864194
     [Google Scholar]
  32. LaiS-W. SungF-C. LinC-L. LiaoK-F. Use of proton pump inhibitors correlates with increased risk of pancreatic cancer: A case-control study in Taiwan.Kuwait Med. J.20144614448
     [Google Scholar]
  33. FujimotoM. HiguchiT. HosomiK. TakadaM. Association between statin use and cancer: Data mining of a spontaneous reporting database and a claims database.Int. J. Med. Sci.201512322323310.7150/ijms.1065625678839
     [Google Scholar]
  34. KhoP.F. FawcettJ. FritschiL. RischH. WebbP.M. WhitemanD.C. NealeR.E. Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: A population-based case–control study.Cancer Causes Control201627121457146410.1007/s10552‑016‑0824‑427817122
     [Google Scholar]
  35. KabatG.C. KimM.Y. ChlebowskiR.T. VitolinsM.Z. Wassertheil-SmollerS. RohanT.E. Serum lipids and risk of obesity-related cancers in postmenopausal women.Cancer Causes Control2018291132410.1007/s10552‑017‑0991‑y29197994
     [Google Scholar]
  36. SzkloM. NietoF.J. Epidemiology: beyond the basics.Jones & Bartlett Publishers2014
     [Google Scholar]
  37. SerruysP.W. de FeyterP. MacayaC. KokottN. PuelJ. VrolixM. BranziA. BertolamiM.C. JacksonG. StraussB. MeierB. Lescol Intervention Prevention Study (LIPS) Investigators Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: A randomized controlled trial.JAMA2002287243215322210.1001/jama.287.24.321512076217
     [Google Scholar]
  38. KayeJ.A. JickH. Statin use and cancer risk in the general practice research database.Br. J. Cancer200490363563710.1038/sj.bjc.660156614760377
     [Google Scholar]
  39. StrandbergT.E. PyöräläK. CookT.J. WilhelmsenL. FaergemanO. ThorgeirssonG. PedersenT.R. KjekshusJ. 4S Group Mortality and incidence of cancer during 10-year follow-up of the scandinavian simvastatin survival study (4S).Lancet2004364943677177710.1016/S0140‑6736(04)16936‑515337403
     [Google Scholar]
  40. SatoS. AjikiW. KobayashiT. AwataN. PCS Study Group Pravastatin use and the five-year incidence of cancer in coronary heart disease patients: From the prevention of coronary sclerosis study.J. Epidemiol.200616520120610.2188/jea.16.20116951539
     [Google Scholar]
  41. PetoR. EmbersonJ. LandrayM. BaigentC. CollinsR. ClareR. CaliffR. Analyses of cancer data from three ezetimibe trials.N. Engl. J. Med.2008359131357136610.1056/NEJMsa080660318765432
     [Google Scholar]
  42. MarelliC. GunnarssonC. RossS. HaasS. StroupD.F. CloadP. CloptonP. DeMariaA.N. Statins and risk of cancer: A retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans.J. Am. Coll. Cardiol.201158553053710.1016/j.jacc.2011.04.01521777752
     [Google Scholar]
  43. VinogradovaY. CouplandC. Hippisley-CoxJ. Exposure to statins and risk of common cancers: A series of nested case-control studies.BMC Cancer201111140910.1186/1471‑2407‑11‑40921943022
     [Google Scholar]
  44. LeungH.W.C. ChanA.L.F. LoD. LeungJ.H. ChenH.L. Common cancer risk and statins: A population-based case–control study in a Chinese population.Expert Opin. Drug Saf.2013121192710.1517/14740338.2013.74439223199231
     [Google Scholar]
  45. DaweD.E. YeX. CzaykowskiP. JassalD. SinghH. SkarsgardD. AprikianA. MahmudS.M. The effect of statin use on the incidence of prostate cancer: A population‐based nested case–control study.Int. J. Cancer2018143119019810.1002/ijc.3129529405283
     [Google Scholar]
  46. CraveiroN.S. Silva LopesB. TomásL. Fraga AlmeidaS. PalmaH. AfreixoV. Costa MatosL. L-TRUST: Long-term risk of cancer in patients under statins therapy. A systematic review and meta-analysis.Pharmacoepidemiol. Drug Saf.201928111431143910.1002/pds.489531509302
     [Google Scholar]
  47. WangY. WangW. WangM. ShiJ. JiaX. DangS. A meta-analysis of statin use and risk of hepatocellular carcinoma.Can. J. Gastroenterol. Hepatol.2022202211510.1155/2022/538904435356132
     [Google Scholar]
  48. DuBrayB.J.Jr ChapmanW.C. AndersonC.D. Hepatocellular carcinoma: A review of the surgical approaches to management.Mo. Med.2011108319519821736080
     [Google Scholar]
  49. ShiY. MoX. HongS. LiT. ChenB. ChenG. Studying the role and molecular mechanisms of MAP4K3 in sorafenib resistance of hepatocellular carcinoma.BioMed Res. Int.202020201810.1155/2020/496567033204699
     [Google Scholar]
  50. KarbowskaE. SwieczkowskiD. GaseckaA. PrucM. SafiejkoK. LadnyJ.R. KopiecT. JaguszewskiM.J. FilipiakK.J. RafiqueZ. SzarpakL. Statins and the risk of pancreatic cancer: A systematic review and meta-analysis of 2,797,186 patients.Cardiol. J.202210.5603/CJ.a2022.001435373328
     [Google Scholar]
/content/journals/cdrr/10.2174/0125899775281869240311043637
Loading
The Relationship between Statin Intake and Risk of Pancreatic Cancer: A Systematic Review and Meta-analysis
Current Drug Research Reviews 17, 311 (2025); https://doi.org/10.2174/0125899775281869240311043637
/content/journals/cdrr/10.2174/0125899775281869240311043637
/content/journals/cdrr/10.2174/0125899775281869240311043637
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): meta-analysis; mortality; pancreas neoplasm; pancreatic cancer; Statin; systematic review

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test